These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: PET-FDG of pleomorphic xanthoastrocytoma.
    Author: Bicik I, Raman R, Knightly JJ, Di Chiro G, Fulham MJ.
    Journal: J Nucl Med; 1995 Jan; 36(1):97-9. PubMed ID: 7799091.
    Abstract:
    A young patient with pleomorphic xanthoastrocytoma (PXA), a usually benign cerebral tumor, had two recurrences in a short time period. The clinical, pathological and neuroradiological features, including PET with [18F]-fluorodeoxyglucose (FDG), are presented. The PET-FDG study revealed the recurrent tumor to be hypermetabolic. The diagnosis was confirmed histopathologically. As the clinical outcome of patients harboring PXA is not easy to predict because of possible recurrence and/or transformation into more aggressive gliomas, we discuss the predictive indicators of more aggressive clinical behavior.
    [Abstract] [Full Text] [Related] [New Search]